However, the co-upregulation of both, MYCN protein and the miR-17-92 cluster miRNAs, in MNA neuroblastoma suggests that miRNA-dependent regulation of MYCN expression is substantially modulated by trans-acting factors controlling MYCN expression via the 3’UTR. The gene discussed is MYCN; the disease is neuroblastoma.